Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
3 months
Pareto SecuritiesCarnegieDanske BankBryan GarnierDanske Bank Markets

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
Pareto Securities340 SEKApr 25
Carnegie385 SEKApr 25
Danske Bank403 SEKOct -22
Bryan Garnier400 SEKFeb -22
Danske Bank Markets448 SEKJun -21

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion